JP2022519570A5 - - Google Patents
Info
- Publication number
- JP2022519570A5 JP2022519570A5 JP2021544796A JP2021544796A JP2022519570A5 JP 2022519570 A5 JP2022519570 A5 JP 2022519570A5 JP 2021544796 A JP2021544796 A JP 2021544796A JP 2021544796 A JP2021544796 A JP 2021544796A JP 2022519570 A5 JP2022519570 A5 JP 2022519570A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024174033A JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1901547.8 | 2019-02-05 | ||
| GBGB1901547.8A GB201901547D0 (en) | 2019-02-05 | 2019-02-05 | Stabilized Fc Fusion protein solutions |
| PCT/GB2020/050255 WO2020161487A1 (en) | 2019-02-05 | 2020-02-05 | STABILIZED Fc FUSION PROTEIN SOLUTIONS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174033A Division JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519570A JP2022519570A (ja) | 2022-03-24 |
| JP2022519570A5 true JP2022519570A5 (https=) | 2023-02-14 |
| JPWO2020161487A5 JPWO2020161487A5 (https=) | 2023-02-14 |
Family
ID=65996928
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544796A Pending JP2022519570A (ja) | 2019-02-05 | 2020-02-05 | 安定化Ｆｃ融合タンパク質溶液 |
| JP2024174033A Pending JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174033A Pending JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220125718A1 (https=) |
| EP (1) | EP3921340A1 (https=) |
| JP (2) | JP2022519570A (https=) |
| GB (1) | GB201901547D0 (https=) |
| WO (1) | WO2020161487A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025084804A1 (ko) * | 2023-10-18 | 2025-04-24 | 주식회사 엘지화학 | Affimer의 안정화 제형 및 그의 제조 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1946776T (pt) | 2002-02-27 | 2017-03-17 | Immunex Corp | Composição de tnfr-fc estabilizada compreendendo arginina |
| KR101335765B1 (ko) * | 2010-01-19 | 2013-12-02 | 한미사이언스 주식회사 | 지속형 에리스로포이에틴 결합체의 액상 제제 |
| BR112013026883A2 (pt) | 2011-04-20 | 2021-12-07 | Sandoz Ag | Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica |
| CN113244374A (zh) | 2011-07-01 | 2021-08-13 | 生物基因Ma公司 | 无精氨酸的tnfr:fc-融合多肽组合物及使用方法 |
| US10485869B2 (en) * | 2011-10-18 | 2019-11-26 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with meglumine |
| EP2919812A4 (en) * | 2012-11-19 | 2016-05-18 | Merck Sharp & Dohme | Liquid formulations for TNFR: FC fusion proteins |
| JP6026002B2 (ja) * | 2012-11-27 | 2016-11-16 | アルテオジェン インコーポレイテッド | タンパク質とＦｃドメインを融合した融合タンパク質の安定化用組成物 |
| BR112015027764A2 (pt) * | 2013-05-02 | 2017-08-29 | Mabxience S A | Formulações alternativas para os polipeptídeos de fusão de tnfr: fc |
| EP3073992A4 (en) * | 2013-11-29 | 2017-09-13 | Ares Trading S.A. | A liquid formulation of a fusion protein comprising tnfr and fc region |
-
2019
- 2019-02-05 GB GBGB1901547.8A patent/GB201901547D0/en not_active Ceased
-
2020
- 2020-02-05 EP EP20705472.7A patent/EP3921340A1/en active Pending
- 2020-02-05 US US17/428,341 patent/US20220125718A1/en active Pending
- 2020-02-05 WO PCT/GB2020/050255 patent/WO2020161487A1/en not_active Ceased
- 2020-02-05 JP JP2021544796A patent/JP2022519570A/ja active Pending
-
2024
- 2024-10-03 JP JP2024174033A patent/JP2025020122A/ja active Pending